More Business Wire
View Older Stories View Newer Stories-
ENHERTU® Followed by THP Before Surgery Resulted in a Pathologic Complete Response in 67% of Patients with High-Risk HER2 Positive Early-Stage Breast Cancer in DESTINY-Breast11 Phase 3 Trial
-
ENHERTU® Reduced the Risk of Disease Recurrence or Death by 53% Versus T-DM1 in Patients with High-Risk HER2 Positive Early Breast Cancer Following Neoadjuvant Therapy in DESTINY-Breast05 Phase 3 Tri
-
ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a pathologic complete response in 67% of patients with high-risk HER2-positive early-stage breast cancer in DESTI
-
Infrrd Announces the Official Launch of Ally: The First Agentic AI Workforce for Mortgage Auditing
-
University of Phoenix College of Social and Behavioral Sciences Leadership Publishes White Paper on Trauma-Informed Education
-
Deciphera Presents 2-Year Efficacy and Safety Results from MOTION Phase 3 Study of ROMVIMZA™ (vimseltinib) in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the European Society for Medical O
-
KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) Demonstrates Durable 5-Year Survival Benefit Versus Chemotherapy for Patients With Advanced Endometrial Carcinoma Following One Prior Platinum-Ba
-
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
-
Salubris Biotherapeutics Announces Dose Escalation Data for JK06, a 5T4-Targeted Antibody Drug Conjugate, at the European Society for Medical Oncology 2025 Congress
-
Exelixis Announces Results from Subgroup Analysis of CABINET Phase 3 Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Advanced Lung and Thymic Neuroendocrine Tumors at ESMO 2025
-
Genentech’s Phase III evERA Data Showed Giredestrant Significantly Improved Progression-Free Survival in People With ER-Positive Advanced Breast Cancer
-
CORRECTING and REPLACING Alliant Insurance Services Expands Transportation Risk and Cross-Border Expertise in Texas through Strategic Acquisition and Key Hires
-
Light & Wonder Statement on NV Legal Proceedings
-
Typhoon Recovery: U-Haul Offers 30 Days Free Storage across Alaska
-
Kolibri Global Energy Inc. Provides Update Regarding Information Circular Disclosure
-
STEP Energy Services Ltd. Agrees to $5.50 Per Share Take Private Transaction With Funds Advised by ARC Financial Corp.
-
Asteria Announces New Animated Short All Heart From Oscar-Winning Filmmakers Michael Govier & Will McCormack and Executive Producer Natasha Lyonne
-
Sensient Announces Conference Call
-
SameDayAbortionPills Notes That While Major Pharmacies Strive to Dispense Abortion Pills Consistently, Occasional Refusals Still Occur Due to Individual Human Factors
-
ALLO Enables Equal Access To Secure Wi-Fi for All Students With Calix SmartTown for Education
-
Granite REIT Declares Distribution for October 2025
-
GreenFirst Welcomes the Restart of Operations at One of Its Key Customers, Kap Paper Inc.
-
AM Best Affirms Credit Ratings of AMEX Assurance Company
-
Arctera Named a Leader in the Gartner® Magic Quadrant™ for Digital Communications Governance and Archiving Solutions
-
The Chequit Announces Seasonal Winter Closure
-
FCPT Announces Acquisition of a Heartland Dental Property for $3.3 Million
-
PFD, PFO, FFC, FLC and DFP Announce Dividends for November
-
Delek US Holdings to Host Third Quarter 2025 Conference Call on November 7th
-
Eaton to announce third quarter 2025 earnings on November 4, 2025
-
Delek Logistics Partners, LP to Host Third Quarter 2025 Conference Call on November 7th
-
RiverNorth Opportunities Fund, Inc. and RiverNorth/DoubleLine Strategic Opportunity Fund, Inc. Announce Preferred Dividends
-
KBRA Assigns AA+ Rating to North Slope Borough, AK General Obligation Bonds, Series 2025
-
Genentech Presents New Phase III Pivotal Data for Vamikibart in Uveitic Macular Edema (UME), a Serious Cause of Vision Loss
-
TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps
-
Permianville Royalty Trust Announces Monthly Cash Distribution
-
Fubo Announces Inducement Grants Under NYSE Listing Rule 303A.08
-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Humankind Investments Announces Liquidation of the Humankind US Stock ETF
-
Venture Global, Inc. Announces Timing of Third Quarter 2025 Earnings Release and Conference Call
-
Comfort Systems USA Announces Third Quarter 2025 Conference Call and Webcast
-
Old Dominion Freight Line Releases 2024 Sustainability Report
-
Backblaze to Announce Third Quarter 2025 Results on November 6, 2025
-
DoubleVerify to Announce Third Quarter 2025 Financial Results on November 7, 2025
-
Western Alliance Bank Enters Strategic Alliance with Clover Lending Group to Expand Financing Access for Active Adult Communities
-
Woodside Donates MXN$400,000 to Mexican Red Cross
-
Humata Health to Provide Access to Prior Authorization Technology Through Microsoft Dragon Copilot
-
General Atomics Joins International Effort to Tackle One of Fusion’s Biggest Hurdles and Unlock the Secrets of Fusion’s Hottest Particles
-
University of Phoenix Named to 2026 GSV 150
-
Best's Review Looks at Early Costs of Shift to Self-Driving Vehicles
-
Muncy Columbia Financial Corporation Announces Third Quarter 2025 Earnings
